Skip to content

Clinical trials

Phase 4 Leukemia, Myeloid, Acute trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 4 Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20032
20051
20061
20073
20092
20105
20133
20151
20162
20172
20193
20223
20243
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Unknown status11
Recruiting6
Active, not recruiting2
Terminated1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
PETHEMA Foundation4
Technische Universität Dresden3
AbbVie2
Novartis Pharmaceuticals2
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine2
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh1
Centre Hospitalier Universitaire, Amiens1
Changhai Hospital1
Cytovia, Inc.1
Fox Chase Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute41
Leukemia7
Myelodysplastic Syndromes6
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Carcinoma, Hepatocellular2
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Renal Cell2
Esophageal Neoplasms2
Febrile Neutropenia2
Graft vs Host Disease2

Trials

Showing 51 to 41 of 41. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.